These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Clinical significance of surfactant protein D as a serum marker for evaluating pulmonary fibrosis in patients with systemic sclerosis. Asano Y, Ihn H, Yamane K, Yazawa N, Kubo M, Fujimoto M, Tamaki K. Arthritis Rheum; 2001 Jun; 44(6):1363-9. PubMed ID: 11407696 [Abstract] [Full Text] [Related]
9. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis. Hamaguchi Y. J Dermatol; 2010 Jan; 37(1):42-53. PubMed ID: 20175839 [Abstract] [Full Text] [Related]
10. Pulmonary arterial hypertension and severe pulmonary fibrosis in systemic sclerosis patients with a nucleolar antibody. Steen VD, Lucas M, Fertig N, Medsger TA. J Rheumatol; 2007 Nov; 34(11):2230-5. PubMed ID: 17937469 [Abstract] [Full Text] [Related]
12. Elevated serum concentrations of polymorphonuclear neutrophilic leukocyte elastase in systemic sclerosis: association with pulmonary fibrosis. Hara T, Ogawa F, Yanaba K, Iwata Y, Muroi E, Komura K, Takenaka M, Shimizu K, Hasegawa M, Fujimoto M, Sato S. J Rheumatol; 2009 Jan; 36(1):99-105. PubMed ID: 19208531 [Abstract] [Full Text] [Related]
13. Serum levels of monocyte chemotactic protein-3/CCL7 are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis. Yanaba K, Komura K, Kodera M, Matsushita T, Hasegawa M, Takehara K, Sato S. Ann Rheum Dis; 2006 Jan; 65(1):124-6. PubMed ID: 16344498 [Abstract] [Full Text] [Related]
15. Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti-topoisomerase I antibody. Perera A, Fertig N, Lucas M, Rodriguez-Reyna TS, Hu P, Steen VD, Medsger TA. Arthritis Rheum; 2007 Aug; 56(8):2740-6. PubMed ID: 17665460 [Abstract] [Full Text] [Related]
16. Serum levels of KL-6 as a useful marker for evaluating pulmonary fibrosis in patients with systemic sclerosis. Yamane K, Ihn H, Kubo M, Yazawa N, Kikuchi K, Soma Y, Tamaki K. J Rheumatol; 2000 Apr; 27(4):930-4. PubMed ID: 10782818 [Abstract] [Full Text] [Related]
18. Serum levels of interleukin 6 (IL-6), oncostatin M, soluble IL-6 receptor, and soluble gp130 in patients with systemic sclerosis. Hasegawa M, Sato S, Fujimoto M, Ihn H, Kikuchi K, Takehara K. J Rheumatol; 1998 Feb; 25(2):308-13. PubMed ID: 9489824 [Abstract] [Full Text] [Related]